Literature DB >> 3787475

Adrenocortical carcinoma.

K Cohn, L Gottesman, M Brennan.   

Abstract

From 1962 to 1985, 47 patients with carcinoma of the adrenal cortex were treated at Memorial Sloan-Kettering Cancer Institute. There were 21 men and 26 women. Seventy-two percent of the tumors were functional and 28% were nonfunctional. Despite the advent of ultrasonography and computerized tomography, these tumors were infrequently diagnosed until they infiltrated adjacent organs or metastasized to distant sites. Only 30% of patients had tumors confined to the adrenal gland; their mean duration of survival was 5.0 years. Seventy percent of the patients had invasion of the kidney, lymph nodes, liver, diaphragm, and/or pancreas at the initial operation; their mean duration of survival was 2.3 years. Eight patients had reoperation for abdominal recurrences; three of the patients with abdominal recurrence and one additional patient underwent thoracotomy to resect localized lung metastases. The mean duration of survival of these nine patients was 3.5 years, not significantly different from the mean overall survival of 3.1 years. The duration of survival of all patients was not significantly correlated with age, sex, adjuvant therapy, or production of hormones by the tumor. Only two patients were deemed unresectable. Wide en-bloc dissection of the primary tumor, resection of contiguous organs for local invasion, and excision of resectable metastases in the liver and lungs remain the basis of therapy.

Entities:  

Mesh:

Year:  1986        PMID: 3787475

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

Review 1.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

Review 2.  Cytotoxic treatment of adrenocortical carcinoma.

Authors:  H Ahlman; A Khorram-Manesh; S Jansson; B Wängberg; O Nilsson; C E Jacobsson; S Lindstedt
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

3.  Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group.

Authors:  P Icard; P Goudet; C Charpenay; B Andreassian; B Carnaille; Y Chapuis; P Cougard; J F Henry; C Proye
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

Review 4.  Current and emerging therapies for advanced adrenocortical carcinoma.

Authors:  Lyndal J Tacon; Ruth S Prichard; Patsy S H Soon; Bruce G Robinson; Roderick J Clifton-Bligh; Stan B Sidhu
Journal:  Oncologist       Date:  2011-01-06

5.  Recurrence of giant adrenocortical carcinoma in the contralateral adrenal gland 6 years after surgery: report of a case.

Authors:  K Kunieda; S Saji; S Mori; M Katoh; K Miya; K Yasuda; T Mune; K Shimokawa
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Liver resection and ablation for metastatic adrenocortical carcinoma.

Authors:  R Taylor Ripley; Clinton D Kemp; Jeremy L Davis; Russell C Langan; Richard E Royal; Steven K Libutti; Seth M Steinberg; Bradford J Wood; Udai S Kammula; Tito Fojo; Itzhak Avital
Journal:  Ann Surg Oncol       Date:  2011-02-08       Impact factor: 5.344

Review 7.  Incidentalomas of the adrenal gland: 36 operated patients and review of literature.

Authors:  J E Sirén; R K Haapiainen; K T Huikuri; A H Sivula
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

Review 8.  Nonfunctional adrenal cortical carcinoma. Report of a case and review of the literature.

Authors:  E D Fokaefs; M D Melekos; M P Melachrinou; I E Zarakovitis; G A Barbalias
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

9.  Alpha-fetoprotein (AFP)-producing adrenocortical carcinoma--long survival with various therapeutic strategies including a lung resection: report of a case.

Authors:  Wakako Hamanaka; Satoshi Yoneda; Takayuki Shirakusa; Hiroshi Shirahama; Yukie Tashiro; Akinori Iwasaki; Takeshi Shiraishi; Hirohumi Tsuru
Journal:  Surg Today       Date:  2008-02-29       Impact factor: 2.549

10.  Survival rates and prognostic factors in adrenocortical carcinoma.

Authors:  P Icard; A Louvel; Y Chapuis
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.